iA Global Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Buy
18,683
+970
+5% +$25.4K 0.01% 373
2026
Q1
$497K Buy
17,713
+1,649
+10% +$43.9K 0.01% 341
2025
Q4
$400K Sell
16,064
-17,887
-53% -$451K 0.01% 349
2025
Q3
$865K Buy
33,951
+20,501
+152% +$506K 0.01% 307
2025
Q2
$326K Sell
13,450
-5,182
-28% -$121K ﹤0.01% 368
2025
Q1
$472K Buy
18,632
+151
+0.8% +$3.95K 0.01% 346
2024
Q4
$490K Hold
18,481
0.01% 342
2024
Q3
$535K Buy
18,481
+516
+3% +$15.1K 0.01% 376
2024
Q2
$503K Sell
17,965
-1,124
-6% -$30.9K 0.01% 349
2024
Q1
$530K Sell
19,089
-116,066
-86% -$3.22M 0.01% 362
2023
Q4
$3.89M Buy
135,155
+5,568
+4% +$168K 0.09% 170
2023
Q3
$4.3M Buy
129,587
+12,470
+11% +$441K 0.11% 157
2023
Q2
$4.3M Buy
+117,117
New +$4.56M 0.11% 149

Other funds holding PFE

iA Global Asset Management's PFE Position: Q2 2026 in Review

iA Global Asset Management increased its Pfizer (PFE) stake by 5.5% in Q2 2026, buying an estimated $25.4K and bringing the position to 18,683 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #373.

iA Global Asset Management first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.3M in Q3 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • iA Global Asset Management held 18,683 shares of Pfizer worth $450K as of Q2 2026.
  • iA Global Asset Management bought 970 Pfizer shares in Q2 2026, an estimated $25.4K.
  • Pfizer made up 0.01% of iA Global Asset Management's portfolio in Q2 2026, its #373 holding.
  • iA Global Asset Management first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's Pfizer position peaked at $4.3M in Q3 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.